期刊文献+

脱卷积法进行自制尼群地平缓释制剂体内外相关性研究 被引量:17

Evaluation of in vitro/in vivo correlation for three kinds of self-designed sustained-release nitrendipine formulations using deconvolution method
下载PDF
导出
摘要 目的 用脱卷积法进行自制尼群地平缓释制剂体内外相关性的研究。方法 以自制尼群地平口服溶液剂的犬体内血药浓度数据为权函数,根据3种自制尼群地平缓释制剂试验犬体内血药浓度数据,采用脱卷积法计算体内释药特性,与相应的体外释药特性进行比较,考察体内外相关性。结果 用脱卷积法计算3种尼群地平缓释制剂的体内外释药相关性良好。结论 脱卷积法适用于自制尼群地平缓释制剂的体内外相关性研究。 Aim To evaluate the in vitro/in vivo correlation for three kinds of self-designed sustained-release nitrendipine formulations using deconvolution method. Methods The characteristics of in vivo release were calculated by deconvolution method using the data of plasma concentration of three kinds of self-designed sustained-release nitrendipine formulations in healthy dogs, in which the in vivo results of nitrendipine solution after oral administrated to dogs were used as weight function. It was the compared with characteristics of in vitro release to assess the in vitro/in vivo correlations. Results The good correlations of in vitro/in vivo were shown in three kinds of self-designed sustained-release nitrendipine formulations using deconvolution method. Conclusion The deconvolution method exhibited advantage in evaluation of in vitro/in vivo correlation for self-designed sustained-release nitrendipine formulations.
出处 《药学学报》 CAS CSCD 北大核心 2004年第9期738-741,共4页 Acta Pharmaceutica Sinica
基金 "九.五"国家重点科技攻关项目(96-902-02-15).
关键词 脱卷积法 体内外相关性 尼群地平 缓释制剂 deconvolution method in vitro/in vivo correlation nitrendipine sustained-release formulations
  • 相关文献

参考文献5

  • 1Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation models for metformin after administration of modified-release oral dosage forms to healthy human volunteers [ J]. J Pharm Sci, 2001,90(8): 1176 - 1185.
  • 2Krol GJ, Lettieri JT, Yeh SC, et al. Disposition and pharmacokinetics of 14C-nitrendipine in healthy volunteers [J]. J Cardiovasc Pharmacol, 1987,9(Suppl 4) :S122-S128.
  • 3Langenbucher F, Mysicka J. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol oros preparations [J]. Br J Clin Pharmacol,1985,19:151S - 162S.
  • 4Wagner JG. Do you need a pharmacokinetic method, and if so, which one? [J] J Pharmacokin Biopharm, 1975,3(6) :457-478.
  • 5Vaughan DP, Nennis M. Mathematical basis of pointarea deconvolution method for determining in vivo input functions [J]. J Pharm Sci, 1978,67(5) :663 -665.

同被引文献92

引证文献17

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部